Yettwaleqqem
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Tuḍḍiwin n tɣawsiwin 2025TAFFA N TMUSNIWIN TUSNANIN
Ilugan n usḍibbi
Af-d ilugan unṣiben, arraten n umtawa d yileqman i d-ssufɣen yimusnawen d tedbirtin n ṣṣeḥḥa.
Iɣbula unṣiben, yettwamanenTuddsiwin tusnawin d tedbirtin n ṣṣeḥḥa
Isallen yettwaleqqmenAsenqed ussnan ameɣlal
Anekcum s war azal i yimseɣtayenI ɣur n temɣiwent n yimdanen n tẓṛi
Tisuffaɣ d ileqman ixataren
Wali isuffeɣen ineggura
Yettwaleqqem
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Tasleḍt n wul 2025
Asuffeɣ unṣib
Evidence-informed diagnosis of cerebral palsy in community settings
Canadian Paediatric Society
Taseḍṛit n warrac 2026Akk yilugan (126 igmuḍ)
Imsizzel
Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron...
Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]”...
Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a...
Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada [2022-06-29]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program i...
Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COV...
Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 year...
Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster do...
Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vacci...
Archived 44: Summary of NACI statement: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 44: Summary of NACI statement: Updated guidance on COVID-19 vaccines for individuals who are pregn...
Archived 44: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding [2022-09-09]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 44: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding [2022-...